SCHEMBL22315710

SCHEMBL22315710

CC(Cc1cnn[nH]1)OCC(=O)O

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22316983 1.00 HCAR2 (0.30) HCAR2
Hydrochloric Acid SCHEMBL28701466 0.98 — —
Hydrochloric Acid SCHEMBL28701463 0.98 — —
SCHEMBL22315716 0.82 APLNR (0.31) —
SCHEMBL22316960 0.82 APLNR (0.31) —
Hydrochloric Acid SCHEMBL25254223 0.70 SLC22A6 (0.39) —
SCHEMBL15875530 0.70 CYP4F2 (0.36) HCAR2
SCHEMBL24083337 0.70 HCAR2 (0.32) HCAR2
SCHEMBL8773843 0.69 — —
Hydrochloric Acid SCHEMBL28678114 0.69 CYP4F2 (0.36) HCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999236-B Salt of nitrogen-containing heterocyclic compound and solid form, pharmaceutical composition and use of salt thereof 武汉人福创新药物研发中心有限公司 2025-06-10 — — CN disclosed
CN-113999235-B Solid forms of nitrogen-containing heterocyclic compounds, pharmaceutical compositions and uses thereof 武汉人福创新药物研发中心有限公司 2025-06-10 — — CN disclosed
CN-111518101-B Pyrrolopyrimidine derivatives and uses thereof 武汉人福创新药物研发中心有限公司 2022-07-29 — — CN disclosed
CN-113999236-A Salt of nitrogen-containing heterocyclic compound and solid form, pharmaceutical composition and application of salt 武汉人福创新药物研发中心有限公司 2022-02-01 — — CN disclosed
CN-113999235-A Solid forms of nitrogen-containing heterocyclic compounds, pharmaceutical compositions and uses thereof 武汉人福创新药物研发中心有限公司 2022-02-01 — — CN disclosed
CN-113943296-A Pyrrolopyrimidine derivatives and uses thereof 武汉人福创新药物研发中心有限公司 2022-01-18 — — CN disclosed
EP-3919498-A1 PYRROLOPYRIMIDINE DERIVATIVE AND USE THEREOF Wuhan Humanwell Innovative Drug Research and Development Center Limited Company (CN) 2021-12-08 — — EP disclosed
CN-111518101-A Pyrrolopyrimidine derivatives and uses thereof 湖北生物医药产业技术研究院有限公司 2020-08-11 — — CN disclosed
WO-2020156459-A1 PYRROLOPYRIMIDINE DERIVATIVE AND USE THEREOF 湖北生物医药产业技术研究院有限公司 2020-08-06 — — WO disclosed
Send feedback